z-logo
Premium
FACTORS PREDICTING THE EFFICACY OF OSIMERTINIB IN T790M‐MUTATED METASTATIC LUNG ADENOCARCINOMA
Publication year - 2018
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13419_43
Subject(s) - osimertinib , medicine , t790m , adenocarcinoma , lung , oncology , metastatic adenocarcinoma , lung cancer , cancer , ros1

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom